IMR-1A is the metabolite of IMR-1 which is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.

SARS-CoV-2 3CLpro-IN-16 is a covalent inhibitor of SARS-CoV-2 3CLpro activity, exerting its effect by forming a covalent bond with Cys145.

4-Nitroquinoline 1-oxide is a highly carcinogenic modeling compound that induces mutations in bacteria, fungi and animals by forming numerous purine adducts.